Senate Passes Tax Bill Cutting $1 Trillion From Health Care Spending
Senate Republicans approved a tax bill reducing health care spending by $1 trillion over 10 years, affecting 12 million Americans' insurance coverage and state Medicaid programs.
Senate Republicans approved a tax bill reducing health care spending by $1 trillion over 10 years, affecting 12 million Americans' insurance coverage and state Medicaid programs.
A $10.6 billion Medicare fraud scheme involving stolen data and false medical equipment claims leads to federal indictments, spotlighting compliance and regulatory challenges in health insurance.
Fadel Alshalabi, owner of Crestar Labs in Tennessee, sentenced to five years for orchestrating a $129M Medicare and Medicaid kickback and billing fraud scheme involving unauthorized genetic tests.
The imminent expiration of the enhanced health care premium tax credit poses significant risks to insurance affordability and coverage continuity for millions of Americans, especially those with chronic health conditions. Legislative action is critical to prevent premium hikes and coverage loss.
A new Congressional Budget Office report projects 11.8 million Americans could lose health insurance over the next decade under the Senate Republicans' version of the tax bill, highlighting significant insurance coverage challenges ahead.
A dispute over health insurance coverage is central to the death of a teenager with chronic illnesses, highlighting challenges in custody agreements and insurance compliance.
Medicare Fraud Prevention Week spotlights methods to reduce Medicare fraud and errors, with tips from the Senior Medicare Patrol to help beneficiaries monitor their claims effectively.
Top U.S. insurers including Blue Cross Blue Shield, Humana, Cigna, and UnitedHealthCare pledge to streamline prior authorization by 2027, improving patient access and reducing provider burden.
Major US health insurers commit to streamlining prior authorization to speed medical approvals and reduce patient/provider friction by 2027.
Tariffs on medical imports have led U.S. health plans to plan premium increases for 2025 due to rising drug and device costs, impacting payer pricing strategies and market outlooks.